HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful management of the no-reflow syndome after venous graft stenting.

Abstract
The no-reflow phenomenon is often found in venous grafts and every effort to prevent it is worthwhile. We performed an angioplasty on a venous graft in a patient with a NSTE acute coronary syndrome with previous inferior myocardial infarction (1996) and CABG (3 venous grafts ), respectively. The native coronary vessels had significant lesions: 70% left main stenosis, distal circumflex artery occlusion, LAD occlusion after the first diagonal branch and proximal occlusion of the RCA. All of the venous grafts,with the exception of the circumflex, were patent. The latter showed subocclusion and slow flow. This was the culprit lesion for the unstable syndrome. After stenting it, no residual stenosis appeared, but severe no-reflow ensued. The no-reflow phenomenon disappeared after intracoronary eptifibatide infusion and aspiration of the slugging contrast from the vein. Clinically, the patient had no chest pain and his ECG changes normalized.
AuthorsAdrian C Iancu, Alexandra Lazar
JournalThe Journal of invasive cardiology (J Invasive Cardiol) Vol. 17 Issue 12 Pg. E50-1 (Dec 2005) ISSN: 1557-2501 [Electronic] United States
PMID16327040 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Peptides
  • Platelet Aggregation Inhibitors
  • Eptifibatide
Topics
  • Aged
  • Blood Vessel Prosthesis (adverse effects)
  • Eptifibatide
  • Graft Occlusion, Vascular (therapy)
  • Humans
  • Male
  • Myocardial Infarction (surgery)
  • Peptides (therapeutic use)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Postoperative Care
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: